Core Laboratories N.V.
General ticker "CLB" information:
- Sector: Energy
- Industry: Oil & Gas Equipment & Services
- Capitalization: $665.3M (TTM average)
Core Laboratories N.V. follows the US Stock Market performance with the rate: 34.5%.
Estimated limits based on current volatility of 2.6%: low 13.23$, high 13.93$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-05-11, amount 0.01$ (Y0.30%)
- Total employees count: 3600 as of 2022
- US accounted for 34.0% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Economic downturns and volatility, Pandemic risks, Cost cutting measures, War in ukraine and sanctions, Cybersecurity threats
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.57$, 21.01$]
- 2026-12-31 to 2027-12-31 estimated range: [13.20$, 21.92$]
Financial Metrics affecting the CLB estimates:
- Positive: with PPE of 21.5 at the end of fiscal year the price was low
- Positive: 7.54 < Operating profit margin, % of 9.59
- Positive: Industry operating cash flow per share per price (median), % of 15.47 > 10.39
- Positive: Interest expense per share per price, % of 1.39 <= 3.31
- Positive: 42.59 < Shareholder equity ratio, % of 46.86 <= 64.29
- Positive: Industry inventory ratio change (median), % of -0.45 <= -0.16
- Positive: 0.05 < Industry earnings per price (median), % of 4.05
- Positive: 2.88 < Industry operating profit margin (median), % of 8.78
- Negative: Return on assets ratio (scaled to [-100,100]) of 4.73 <= 6.06
- Positive: Investing cash flow per share per price, % of -0.29 > -0.60
Short-term CLB quotes
Long-term CLB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $509.79MM | $523.85MM | $526.52MM |
| Operating Expenses | $455.15MM | $465.29MM | $476.03MM |
| Operating Income | $54.64MM | $58.56MM | $50.49MM |
| Non-Operating Income | $-13.43MM | $-12.37MM | $-4.59MM |
| Interest Expense | $13.43MM | $12.37MM | $10.57MM |
| Income(Loss) | $41.21MM | $46.19MM | $45.90MM |
| Taxes | $4.18MM | $14.03MM | $15.51MM |
| Net Income(Loss)* | $36.67MM | $31.40MM | $31.80MM |
| Stockholders Equity | $224.81MM | $251.99MM | $279.76MM |
| Inventory | $71.70MM | $59.40MM | $54.50MM |
| Assets | $586.39MM | $590.41MM | $596.95MM |
| Operating Cash Flow | $24.79MM | $56.39MM | $37.18MM |
| Capital expenditure | $10.58MM | $13.03MM | $14.59MM |
| Investing Cash Flow | $-6.65MM | $-6.39MM | $-2.23MM |
| Financing Cash Flow | $-18.45MM | $-45.96MM | $-31.25MM |
| Earnings Per Share** | $0.79 | $0.67 | $0.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.